| Acidity generated by the tumor microenvironment drives local invasion V Estrella, T Chen, M Lloyd, J Wojtkowiak, HH Cornnell, ... Cancer research 73 (5), 1524-1535, 2013 | 1034 | 2013 |
| 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? JL Messina, DA Fenstermacher, S Eschrich, X Qu, AE Berglund, MC Lloyd, ... Scientific reports 2 (1), 1-6, 2012 | 298 | 2012 |
| Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments JW Wojtkowiak, JM Rothberg, V Kumar, KJ Schramm, E Haller, ... Cancer research 72 (16), 3938-3947, 2012 | 222 | 2012 |
| Darwinian dynamics of intratumoral heterogeneity: not solely random mutations but also variable environmental selection forces MC Lloyd, JJ Cunningham, MM Bui, RJ Gillies, JS Brown, RA Gatenby Cancer research 76 (11), 3136-3144, 2016 | 199 | 2016 |
| Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions H Perfahl, HM Byrne, T Chen, V Estrella, T Alarcón, A Lapin, RA Gatenby, ... PloS one 6 (4), e14790, 2011 | 188 | 2011 |
| A physical sciences network characterization of non-tumorigenic and metastatic cells TPSOC Network, DB Agus, JF Alexander, W Arap, S Ashili, JE Aslan, ... Scientific reports 3, 1449, 2013 | 146 | 2013 |
| Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane M Damaghi, NK Tafreshi, MC Lloyd, R Sprung, V Estrella, JW Wojtkowiak, ... Nature communications 6 (1), 1-13, 2015 | 138 | 2015 |
| Systemic buffers inhibit carcinogenesis in TRAMP mice A Ibrahim-Hashim, HH Cornnell, D Abrahams, M Lloyd, M Bui, RJ Gillies, ... The Journal of urology 188 (2), 624-631, 2012 | 111 | 2012 |
| Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases NK Tafreshi, MC Lloyd, MM Bui, RJ Gillies, DL Morse Carbonic anhydrase: Mechanism, regulation, links to disease, and industrial …, 2014 | 103 | 2014 |
| Defining cancer subpopulations by adaptive strategies rather than molecular properties provides novel insights into intratumoral evolution A Ibrahim-Hashim, M Robertson-Tessi, PM Enriquez-Navas, M Damaghi, ... Cancer research 77 (9), 2242-2254, 2017 | 96 | 2017 |
| Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it? MC Lloyd, P Allam-Nandyala, CN Purohit, N Burke, D Coppola, MM Bui Journal of pathology informatics 1, 2010 | 94 | 2010 |
| Reduction of metastasis using a non-volatile buffer A Ibrahim Hashim, HH Cornnell, ML Coelho Ribeiro, D Abrahams, ... Clinical & experimental metastasis 28 (8), 841-849, 2011 | 92 | 2011 |
| ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors P Dasgupta, W Rizwani, S Pillai, R Davis, S Banerjee, K Hug, M Lloyd, ... Journal of the National Cancer Institute 103 (4), 317-333, 2011 | 92 | 2011 |
| MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion J Gao, MJ McConnell, B Yu, J Li, JM Balko, EP Black, JO Johnson, ... International journal of oncology 35 (2), 337-345, 2009 | 91 | 2009 |
| Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes NK Tafreshi, MM Bui, K Bishop, MC Lloyd, SA Enkemann, AS Lopez, ... Clinical Cancer Research 18 (1), 207-219, 2012 | 85 | 2012 |
| Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy R Ramakrishnan, C Huang, HI Cho, M Lloyd, J Johnson, X Ren, S Altiok, ... Cancer research 72 (21), 5483-5493, 2012 | 83 | 2012 |
| The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor–positive metastatic breast cancer SA Wander, O Cohen, X Gong, GN Johnson, JE Buendia-Buendia, ... Cancer discovery 10 (8), 1174-1193, 2020 | 81 | 2020 |
| Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistance D Verduzco, M Lloyd, L Xu, A Ibrahim-Hashim, Y Balagurunathan, ... PloS one 10 (3), e0120958, 2015 | 79 | 2015 |
| Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer AG Waks, O Cohen, B Kochupurakkal, D Kim, CE Dunn, JB Buendia, ... Annals of Oncology 31 (5), 590-598, 2020 | 69 | 2020 |
| Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302 JW Wojtkowiak, HC Cornnell, S Matsumoto, K Saito, Y Takakusagi, ... Cancer & metabolism 3 (1), 1-13, 2015 | 68 | 2015 |
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterBestätigte E-Mail-Adresse bei moffitt.org
